Plain-English translation of NCT06100770 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study is evaluating how well the Aveir AR leadless pacemaker works compared to standard single-chamber pacemakers in real-world patients. Researchers will look at health records from Medicare patients who have received either device to understand if the new design offers any benefits or differences in outcomes.
Leadless pacemakers are a newer technology designed to avoid some of the complications that can occur with traditional pacemakers that use leads and wires. This study will help doctors and insurance companies understand whether this newer approach is beneficial for patients who need a pacemaker.
You likely qualify if…
You likely don't qualify if…
Your participation involves allowing researchers to access your existing Medicare medical records and claims data — no additional visits, procedures, or tests are required. The study uses information that is already collected as part of your regular medical care, so your involvement is entirely passive. Your records will be compared with other patients' records to help researchers understand how the two types of pacemakers perform over time.
AI-generated summary from trial data · Jul 19, 2026 · Not medical advice
United States
Enrollment target
~586 participants
Started
January 2024
Primary completion
January 2030
Age range
18 Years and older
Last updated on clinicaltrials.gov in April 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Nicole Harbert
Abbott
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.